Platelet Rich Plasma (PRP) Tubes Market Research Report and Outlook by 2028

The worldwide market for platelet-rich plasma (PRP) tubes is projected to grow significantly, reaching approximately US$ 1,640.94 million by 2028, up from US$ 565.10 million in 2021. This growth represents a compound annual growth rate (CAGR) of 16.5% from 2022 to 2028.

The expansion of this market is primarily driven by the increasing prevalence of cosmetic and aesthetic procedures, alongside a rise in sports-related injuries. Nevertheless, the high costs associated with PRP treatments and potential adverse effects are posing challenges to the growth of the platelet-rich plasma (PRP) tubes market.

Surge in Sports Injuries Fuels Demand for Platelet-Rich Plasma (PRP) Tubes

Effective treatment of sports injuries necessitates skilled medical professionals employing advanced techniques to ensure athletes can return to their activities promptly. The growing participation in sports has led to a corresponding increase in injuries. A report from the Saudi Journal of Sports Medicine indicates that in Jeddah, 50% of sports injuries among athletes are linked to soccer, while 34% are associated with basketball as of 2020.

In the UAE, Anterior Cruciate Ligament (ACL) injuries, which are significant knee injuries, account for approximately 40% of all sports injuries, according to estimates from the Arab Health report. Alarmingly, these injuries are reported to be about five times more prevalent in the UAE compared to other nations.

In 2021, emergency departments treated around 3.2 million individuals for injuries related to sports and recreational activities. The National Safety Council (NSC) reported that exercise, cycling, and basketball were among the most common activities leading to injuries. Specifically, in 2021, around 409,000 injuries were attributed to exercise equipment, marking the highest incidence in any sports and recreation category. PRP injections are increasingly utilized to promote healing in athletes who have sustained sports injuries through minimally invasive procedures. The PRP treatment involves drawing the patient?s blood, which is then processed through centrifugation to separate the plasma from blood cells, and subsequently injected into the injured area. The concentrated plasma contains growth factors that enhance the healing process and recovery time. PRP injections have gained popularity for treating injuries to tendons, muscles, and ligaments. A report from the National Library of Medicine in 2021 noted a rise in injury rates among soccer players in recent years, often attributed to increased specialization in sports and rigorous training at young ages. Additionally, a report by Statista Research Department in 2022 highlighted that skiers in France experienced the highest frequency of injuries in 2020, with over 50% of these injuries affecting the legs and knees during the 2019-2020 season.

Consequently, the growing incidence of sports injuries is driving the demand for PRP therapies among athletes, thereby contributing to the expansion of the platelet-rich plasma (PRP) tube market.

In India, the number of COVID-19 cases has significantly decreased compared to previous trends. The pandemic's impact, including disruptions in supply chains due to prolonged factory closures and production delays, was felt for a limited time. However, as demand outstripped supply, prices for commodities rose. During the pandemic, the focus on dermatological treatments diminished as healthcare resources were redirected towards COVID-19 patient care, with dermatology clinics, hospitals, and surgical centers primarily operating for emergencies. China faced numerous challenges that disrupted supply chains, leading to projected declines in revenue and sales across various sectors, particularly in the beauty industry. The downturn in medical tourism during the pandemic in South Korea, Japan, and other regions adversely affected the market.

The platelet-rich plasma (PRP) tubes market is categorized by usage into segments such as skin rejuvenation, hair restoration, orthopedics, surgical oncology, gynecology, and others. The orthopedics segment dominated the market in 2021, while the skin rejuvenation segment is expected to exhibit the highest CAGR during the forecast period.

Regarding application, the PRP market is divided into categories based on volume: less than 5ml, 6ml to 10ml, and more than 10ml. The segment for more than 10ml accounted for the largest market share in 2021 and is projected to experience the highest CAGR in the upcoming years.

By end user, the market is segmented into medspas, dermatology offices, hospitals and healthcare practices, trichologists, and others. The hospitals and healthcare practices segment held the largest market share in 2021 and is anticipated to register the highest CAGR during the forecast period.

Key sources referenced in the preparation of this report on the platelet-rich plasma (PRP) market include the Centers for Disease Control and Prevention, the Organisation for Economic Co-operation and Development (OECD), the International Trade Administration (ITA), CEIC: Global Economic Data, Indicators, Charts & Forecasts, Japan's Ministry of Land, Infrastructure, Transport, and Tourism, and the India Brand Equity Foundation (IBEF).